BST1 and neoplasm: This data indicates that CD157 is involved in EMT and suggests that the CD157/ECM interplay in the tumor microenvironment could be critical in determining the aggressiveness of CD157-positive tumors by facilitating the EMT differentiation program ongoing in biphasic MPM [5, 22].